SEC Form 4 · accession 0001094891-18-000156
PAVmed Inc. · PAVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian J. DeGuzman
Officer — Chief Medical Officer
Period of report
Jun 26, 2018
Accepted (ET)
Jul 12, 2018 · 3:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624326
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series Z Warrants | $1.60 | Jun 26, 2018 | J | 322,673 | A | Apr 5, 2018 | Apr 30, 2024 | Common Stock | 322,673 | 322,673 | I |
| Series Z Warrants | $1.60 | Jun 26, 2018 | J | 322,673 | D | Apr 5, 2018 | Apr 30, 2024 | Common Stock | 322,673 | 0 | I |
Explanation of responses
- F1Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member.
- F2Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member.